StockWatch
·
Healthcare Research- Analytics & Technology
Board Meeting13 Aug 2026, 02:57 pm

Jeevan Scientific Board Approves Q1 FY27 Un-audited Results, Director Re-appointments

AI Summary

Jeevan Scientific Technology Limited's Board of Directors convened on August 13, 2026, approving the un-audited financial results for the quarter ended June 30, 2026 (Standalone and Consolidated). The board also approved several re-appointments of Whole Time Directors and Independent Directors, subject to shareholder approval. These include the re-appointment of Mrs. Snigdha Mothukuri and Mr. Nageswar Rao Yarllagadda as Whole Time Directors, and Mr. Suryaprakasa Rao Bommisetti as an Independent Director. Additionally, Mr. Kolli Srinivas Rao was appointed as an additional Independent Director. The company also announced the Annual General Meeting for FY 2025-26 will be held on September 25, 2026, and distributed the Directors' Report and other related documents.

Key Highlights

  • Board approved un-audited financial results for Q1 FY27.
  • Several director re-appointments and one new appointment approved.
  • Appointments are subject to shareholder approval.
  • AGM for FY 2025-26 scheduled for September 25, 2026.
  • Director and Independent Director terms extended.